FdaApplication
ANDA 214095
Identifiers
- fda_app_no: ANDA214095
Properties
| Property | Value |
|---|---|
| applicant_name | APOTEX INC |
| application_type | ANDA |
| approval_date | 2026-01-30 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EMTRICITABINE, RILPIVIRINE, AND TENOFOVIR ALAFENAMIDE | EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE | 200MG;EQ 25MG BASE;EQ 25MG BASE | TABLET;ORAL |
1 product